| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1002243135 |
| P356 | DOI | 10.1038/ONC.2016.340 |
| P932 | PMC publication ID | 5383522 |
| P698 | PubMed publication ID | 27721404 |
| P50 | author | Marien Pascual | Q42583806 |
| John Greally | Q42667137 | ||
| Fabien Delahaye | Q56991999 | ||
| P2093 | author name string | A W Wolkoff | |
| A Verma | |||
| J Tozour | |||
| M Adeyeye | |||
| M Alani | |||
| N A Wijetunga | |||
| P2860 | cites work | Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains | Q21092474 |
| Model-based analysis of ChIP-Seq (MACS) | Q21183902 | ||
| Genome-wide conserved consensus transcription factor binding motifs are hyper-methylated | Q21267215 | ||
| An integrated encyclopedia of DNA elements in the human genome | Q22122150 | ||
| Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP | Q22253279 | ||
| The Polycomb group protein EZH2 directly controls DNA methylation | Q24299020 | ||
| Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer | Q24299591 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| The accessible chromatin landscape of the human genome | Q24595581 | ||
| Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression | Q24606745 | ||
| The Cancer Genome Atlas Pan-Cancer analysis project | Q24606808 | ||
| Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma | Q24609544 | ||
| The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores | Q24649374 | ||
| CpG island methylator phenotype in colorectal cancer | Q24672170 | ||
| Worms gang up on bacteria | Q27860588 | ||
| CpG islands in vertebrate genomes | Q27861045 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| CpG-rich islands and the function of DNA methylation | Q28131800 | ||
| Embryonic Lethality and Fetal Liver Apoptosis in Mice Lacking All Three Small Maf Proteins | Q28255180 | ||
| Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes | Q28270020 | ||
| The epigenomics of cancer | Q28289975 | ||
| Jun dimerization protein 2 is a critical component of the Nrf2/MafK complex regulating the response to ROS homeostasis | Q28301972 | ||
| Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3 | Q28569202 | ||
| C/EBP-beta regulates endoplasmic reticulum stress-triggered cell death in mouse and human models | Q28748676 | ||
| DNA-binding factors shape the mouse methylome at distal regulatory regions | Q42818364 | ||
| Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis | Q43031864 | ||
| Methylation at the CpG island shore region upregulates Nr3c1 promoter activity after early-life stress | Q43199557 | ||
| Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma | Q43275503 | ||
| Cancer-associated molecular signature in the tissue samples of patients with cirrhosis. | Q45966861 | ||
| RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. | Q46123728 | ||
| Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. | Q46873710 | ||
| Convergence of Wnt signaling on the HNF4alpha-driven transcription in controlling liver zonation | Q47767379 | ||
| A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells | Q50115050 | ||
| β-Catenin signaling regulates Foxa2 expression during endometrial hyperplasia formation. | Q50786902 | ||
| DNA methylation of transcriptional enhancers and cancer predisposition | Q50857668 | ||
| Competition between DNA methylation and transcription factors determines binding of NRF1. | Q51564541 | ||
| Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling | Q52087746 | ||
| Hepatitis C Virus Inhibits DNA Damage Repair through Reactive Oxygen and Nitrogen Species and by Interfering with the ATM-NBS1/Mre11/Rad50 DNA Repair Pathway in Monocytes and Hepatocytes | Q39639979 | ||
| Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2. | Q39731654 | ||
| Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation. | Q39806271 | ||
| EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma | Q40006245 | ||
| Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration | Q40295592 | ||
| Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260. | Q40301526 | ||
| Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus | Q40588817 | ||
| Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis? | Q41369277 | ||
| Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma | Q41918713 | ||
| Effects of EZH2 gene on the growth and migration of hepatocellular carcinoma HepG2 cells | Q41955698 | ||
| Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment | Q53343023 | ||
| The fundamental role of epigenetic events in cancer | Q56421597 | ||
| Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer | Q56762983 | ||
| Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response | Q67895445 | ||
| Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA | Q80166978 | ||
| Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q84424049 | ||
| Definition of the landscape of promoter DNA hypomethylation in liver cancer | Q84540607 | ||
| Faddish Stuff: Epigenetics and the Inheritance of Acquired Characteristics | Q85831455 | ||
| Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets | Q38400913 | ||
| Interferon-free therapy for hepatitis C: The hurdles amid a golden era. | Q38456786 | ||
| A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma | Q39084747 | ||
| Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma | Q39290981 | ||
| Optimized design and data analysis of tag-based cytosine methylation assays | Q28751637 | ||
| Functions of DNA methylation: islands, start sites, gene bodies and beyond | Q29547260 | ||
| Epigenetics in cancer | Q29547853 | ||
| A unique chromatin signature uncovers early developmental enhancers in humans | Q29614327 | ||
| Cancer epigenetics comes of age | Q29617275 | ||
| Global epigenomic reconfiguration during mammalian brain development | Q29617800 | ||
| Epigenetic stem cell signature in cancer | Q29622897 | ||
| Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer | Q29622925 | ||
| Comparative annotation of functional regions in the human genome using epigenomic data | Q30597594 | ||
| The meta-epigenomic structure of purified human stem cell populations is defined at cis-regulatory sequences | Q30616764 | ||
| A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing | Q33268624 | ||
| Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors | Q33543795 | ||
| A pipeline for the quantitative analysis of CG dinucleotide methylation using mass spectrometry | Q33567042 | ||
| DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes | Q33742114 | ||
| Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis. | Q33826718 | ||
| Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. | Q33831996 | ||
| Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis | Q33869648 | ||
| DNA hypermethylation in tumorigenesis: epigenetics joins genetics | Q33870798 | ||
| Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. | Q33888431 | ||
| Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues | Q33893082 | ||
| Gene expression patterns in human liver cancers | Q33898932 | ||
| The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy | Q33914312 | ||
| Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data | Q33951424 | ||
| High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. | Q33966440 | ||
| Intermediate methylation epigenotype and its correlation to KRAS mutation in conventional colorectal adenoma | Q34083336 | ||
| Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer | Q34153828 | ||
| Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction | Q34193813 | ||
| Gene expression in fixed tissues and outcome in hepatocellular carcinoma. | Q34235518 | ||
| Sexual dimorphism in epigenomic responses of stem cells to extreme fetal growth | Q34339426 | ||
| A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. | Q34579605 | ||
| Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma | Q34598189 | ||
| On the use of the word 'epigenetic'. | Q34615615 | ||
| Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype | Q34619635 | ||
| The initiation of liver development is dependent on Foxa transcription factors | Q34650705 | ||
| The oncogenic role of hepatitis C virus | Q34655920 | ||
| Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress | Q34801719 | ||
| Transcription factor occupancy can mediate active turnover of DNA methylation at regulatory regions. | Q35075152 | ||
| Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions | Q35145499 | ||
| HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells | Q35208702 | ||
| Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival | Q35582141 | ||
| Genome-wide DNA methylation profiles in hepatocellular carcinoma. | Q35899166 | ||
| Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA | Q36021714 | ||
| Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk | Q36021752 | ||
| Epigenetics and colorectal cancer | Q36081553 | ||
| Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis | Q36089332 | ||
| Genome-wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites | Q36130839 | ||
| Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment | Q36142013 | ||
| Hippo signaling influences HNF4A and FOXA2 enhancer switching during hepatocyte differentiation | Q36182106 | ||
| Expression of hepatic transcription factors during liver development and oval cell differentiation | Q36234412 | ||
| DNA methylation and gene silencing in cancer | Q36338042 | ||
| Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma | Q36547263 | ||
| Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips | Q36548047 | ||
| Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes | Q36684233 | ||
| Hepatocyte nuclear factor 4alpha contributes to thyroid hormone homeostasis by cooperatively regulating the type 1 iodothyronine deiodinase gene with GATA4 and Kruppel-like transcription factor 9. | Q36710816 | ||
| Gene-expression signature of vascular invasion in hepatocellular carcinoma. | Q36759564 | ||
| Focal gains of VEGFA and molecular classification of hepatocellular carcinoma | Q36984575 | ||
| Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons. | Q37022861 | ||
| Endoplasmic reticulum stress impairs IL-4/IL-13 signaling through C/EBPβ-mediated transcriptional suppression | Q37132517 | ||
| Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science | Q37170521 | ||
| Pivotal role of mTOR signaling in hepatocellular carcinoma | Q37183244 | ||
| CpG island shore methylation regulates caveolin-1 expression in breast cancer | Q37209244 | ||
| Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma | Q37284612 | ||
| Charting a dynamic DNA methylation landscape of the human genome | Q37292011 | ||
| Liver insulin-like growth factor 2 methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinoma | Q37347288 | ||
| Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes | Q37356991 | ||
| Surgical Resection for Hepatocellular Carcinoma in the Noncirrhotic: The Western Experience | Q38039867 | ||
| An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy | Q38127968 | ||
| The function of chromatin modifiers in lineage commitment and cell fate specification | Q38263642 | ||
| Function and information content of DNA methylation | Q38319920 | ||
| General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells | Q38346570 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International | Q42553662 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2030-2044 | |
| P577 | publication date | 2016-10-10 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets | |
| P478 | volume | 36 |
| Q58724813 | DNA topoisomerase 1 and 2A function as oncogenes in liver cancer and may be direct targets of nitidine chloride |
| Q92001987 | Epigenetic regulation of histone H3 in the process of hepatocellular tumorigenesis |
| Q47157566 | Epigenetic reprogramming in liver fibrosis and cancer |
| Q52809057 | Epigenome-based cancer risk prediction: rationale, opportunities and challenges |
| Q64266344 | Ferroptosis is governed by differential regulation of transcription in liver cancer |
| Q92876708 | Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals |
| Q52673754 | MIRA: An R package for DNA methylation-based inference of regulatory activity |
| Q58760425 | Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications |
| Q40046596 | Viral hepatitis and liver cancer. |
Search more.